1. Shrivastava A, Johnston M, Terpstra K, Stitt L, Shah N. Atypical antipsychotics usage in long-term follow-up of first episode schizophrenia. Indian J Psychiatry. 2012 Jul;54(3):248-52. doi: 10.4103/0019-5545.102425. PMID: 23226849; PMCID: PMC3512362. [cited 2022 July 22]
2. Insel T, “Antipsychotics: Taking the Long View” Open Excellence, (Thomas Insel, former NIMH Director) 2013 Aug, National Institute for Mental Health [cited 2022 July 22]
3. Klawans HL, Tanner CM, Barr A. The reversibility of “permanent” tardive dyskinesia. Clin Neuropharmacol. 1984;7(2):153-9. doi: 10.1097/00002826-198406000-00006. PMID: 6145520. [cited 2022 July 22]
4. Cornett et al., “Medicine-Induced Tardive Dyskinesia: A Review and Update” National Institute for Mental Health [cited 2022 July 22]
5. Crowley et al., “Brain Levels of the Neurotoxic Pyridinium Metabolite HPP+ and Extrapyramidal Symptoms in Haloperidol-Treated Mice.” Neurotoxicology 2013 Dec., PMID24107597 [cited 2022 July 22]
6. FDA drug label Invega (paliperidone} Extended Release Tablets, approved 2006 [cited 2022 July 22]
7. NAMI authors, “Paliperidone (Invega) [published online Feb 2020] [cited 2022 July 22]
8. Oxford References, “Ulysses contract” [published online 2022] [cited 2022 July 22]
9. Keks N, Schwartz D, Hope J. Stopping and switching antipsychotic drugs. Aust Prescr. 2019;42(5):152-157. doi:10.18773/austprescr.2019.052 [cited 2022 July 22]
10. Hedges DW, Woon FL, Hoopes SP. Caffeine-induced psychosis. CNS Spectr. 2009 Mar;14(3):127-9. doi: 10.1017/s1092852900020101. PMID: 19407709. [cited 2022 July 22]
11. Wang HR, Woo YS, Bahk WM. Caffeine-induced psychiatric manifestations: a review. Int Clin Psychopharmacol. 2015 Jul;30(4):179-82. doi: 10.1097/YIC.0000000000000076. PMID: 25856116. [cited 2022 July 22]
12. NIDA. 2020, May 28. Is there a link between marijuana use and psychiatric disorders? [cited 2022 July 22]
13. Henquet C, Di Forti M, Morrison P, Kuepper R, Murray RM. Gene-environment interplay between cannabis and psychosis. Schizophr Bull. 2008;34(6):1111-1121. doi:10.1093/schbul/sbn108. [cited 2022 July 22]
14. Nesvåg R, Frigessi A, Jönsson EG, Agartz I. Effects of alcohol consumption and antipsychotic medication on brain morphology in schizophrenia. Schizophr Res. 2007 Feb;90(1-3):52-61. doi: 10.1016/j.schres.2006.11.008. Epub 2007 Jan 10. PMID: 17218084. [cited 2022 July 22]
15. Wen Q, Chklovskii DB. Segregation of the brain into gray and white matter: a design minimizing conduction delays. PLoS Comput Biol. 2005;1(7):e78. doi:10.1371/journal.pcbi.0010078 [cited 2022 July 22]
16. Sahoo S, Mehra A, Grover S. Acute Hyperglycemia Associated with Psychotic Symptoms in a Patient with Type 1 Diabetes Mellitus: A Case Report. Innov Clin Neurosci. 2016;13(11-12):25-27. Published 2016 Dec 1. [cited 2022 July 22]
17. Hormone Health Network Non-Diabetic Hypoglycemia EDITOR(S): Prof. Margaret Eckert-Norton, PHD, FNP-BC, CDE, Ramon Martinez, M.D., Susan Kirk, M.D. LAST UPDATED: July 2020. [cited 2022 July 22]
18. Sharma A, Madaan V, Petty FD. Exercise for mental health. Prim Care Companion J Clin Psychiatry. 2006;8(2):106. doi:10.4088/pcc.v08n0208a [cited 2022 July 22]
19. Callaghan P. Exercise: a neglected intervention in mental health care? J Psychiatr Ment Health Nurs. 2004 Aug;11(4):476-83. doi: 10.1111/j.1365-2850.2004.00751.x. PMID: 15255923. [cited 2022 July 22]
20. Janssen drug information Invega “How to take Invega” [published online 2019] [cited 2022 July 22]
21. Andrade C. Delayed drug interactions in psychiatry: armodafinil and risperidone as a potential case in point. J Clin Psychiatry. 2015 Dec;76(12):1633-4. doi: 10.4088/JCP.15f10514. PMID: 26717524. [cited 2022 July 22]
22. Brandt L, Bschor T, Henssler J, et al. Antipsychotic Withdrawal Symptoms: A Systematic Review and Meta-Analysis. Front Psychiatry. 2020;11:569912. Published 2020 Sep 29. doi:10.3389/fpsyt.2020.569912 [cited 2022 July 22]
23. Chemerinski E, Ho BC, Flaum M, Arndt S, Fleming F, Andreasen NC. Insomnia as a predictor for symptom worsening following antipsychotic withdrawal in schizophrenia. Compr Psychiatry. 2002 Sep-Oct;43(5):393-6. doi: 10.1053/comp.2002.34627. PMID: 12216015. [cited 2022 July 22]
24. Horowitz MA, Jauhar S, Natesan S, Murray RM, Taylor D. A Method for Tapering Antipsychotic Treatment That May Minimize the Risk of Relapse. Schizophr Bull. 2021 Mar 23:sbab017. doi: 10.1093/schbul/sbab017. Epub ahead of print. PMID: 33754644. [cited 2022 July 22]
25. Aucoin M, LaChance L, Clouthier SN, Cooley K. Dietary modification in the treatment of schizophrenia spectrum disorders: A systematic review. World J Psychiatry. 2020 Aug 19;10(8):187-201. doi: 10.5498/wjp.v10.i8.187. PMID: 32874956; PMCID: PMC7439299. [cited 2022 July 22]
26. Morrison AK. Cognitive behavior therapy for people with schizophrenia. Psychiatry (Edgmont). 2009;6(12):32-39. [cited 2022 July 22]
27. Barnes TR, Paton C. Antipsychotic polypharmacy in schizophrenia: benefits and risks. CNS Drugs. 2011 May;25(5):383-99. doi: 10.2165/11587810-000000000-00000. PMID: 21476610. [cited 2022 July 22]
28. Borlido C, Remington G, Graff-Guerrero A, Arenovich T, Hazra M, Wong A, Daskalakis ZJ, Mamo DC. Switching from 2 antipsychotics to 1 antipsychotic in schizophrenia: a randomized, double-blind, placebo-controlled study. J Clin Psychiatry. 2016 Jan;77(1):e14-20. doi: 10.4088/JCP.14m09321. PMID: 26845273. [cited 2022 July 22]
29. Loughlin AM, Lin N, Abler V, Carroll B. Tardive dyskinesia among patients using antipsychotic medications in customary clinical care in the United States. PLoS One. 2019 Jun 4;14(6):e0216044. doi: 10.1371/journal.pone.0216044. PMID: 31163035; PMCID: PMC6548364.[cited 2022 July 22]
30. Jeste D V, et al, “Tardive Dyskinesia-Reversible and Permanent” JAMA May 1979 [cited 2022 July 22]
31. Yin J, Barr AM, Ramos-Miguel A, Procyshyn RM. Antipsychotic Induced Dopamine Supersensitivity Psychosis: A Comprehensive Review. Curr Neuropharmacol. 2017;15(1):174-183. doi:10.2174/1570159×14666160606093602 [cited 2022 July 22]
32. MacNeil RR, Müller DJ. Genetics of Common Antipsychotic-Induced Adverse Effects. Mol Neuropsychiatry. 2016;2(2):61-78. doi:10.1159/000445802 [cited 2022 July 22]